Follow
Veli-Matti Isoviita
Veli-Matti Isoviita
Unknown affiliation
Verified email at helsinki.fi
Title
Cited by
Cited by
Year
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD
AE Renton, E Majounie, A Waite, J Simón-Sánchez, S Rollinson, ...
Neuron 72 (2), 257-268, 2011
47222011
Hantaviruses in Finnish soricomorphs: Evidence for two distinct hantaviruses carried by Sorex araneus suggesting ancient host-switch
J Ling, T Sironen, L Voutilainen, S Hepojoki, J Niemimaa, VM Isoviita, ...
Infection, Genetics and Evolution 27, 51-61, 2014
322014
Genome‐wide association study of neocortical Lewy‐related pathology
T Peuralinna, L Myllykangas, M Oinas, MA Nalls, HAD Keage, VM Isoviita, ...
Annals of clinical and translational neurology 2 (9), 920-931, 2015
302015
Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma
A Lahtinen, K Lavikka, A Virtanen, Y Li, S Jamalzadeh, A Skorda, ...
Cancer Cell 41 (6), 1103-1117. e12, 2023
162023
Consortium ITALSGEN
AE Renton, E Majounie, A Waite, J Simón-Sánchez, S Rollinson, ...
Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C …, 2011
152011
Open source infrastructure for health care data integration and machine learning analyses
VM Isoviita, L Salminen, J Azar, R Lehtonen, P Roering, O Carpén, ...
JCO Clinical Cancer Informatics 3, 1-16, 2019
132019
Hospital physicians working hour characteristics and sleep quality: a cross-sectional analysis of realized working hour and survey data
K Karhula, A Koskinen, J Ervasti, T Hakola, VM Isoviita, I Kivimäki, ...
BMC Health Services Research 22 (1), 943, 2022
122022
Sähköisten terveyspalveluiden opetus lääketieteessä
T Tuovinen, J Reponen, VM Isoviita, T Koskela, A Levy, J Pääkkönen, ...
Suomalainen lääkäriseura Duodecim, 2021
52021
HRD related signature 3 predicts clinical outcome in advanced tubo-ovarian high-grade serous carcinoma
H Koskela, Y Li, T Joutsiniemi, T Muranen, VM Isoviita, K Huhtinen, ...
Gynecologic Oncology 180, 91-98, 2024
22024
High-level biomedical data integration in a semantic knowledge graph with oncodashkb for finding personalized actionable drugs in ovarian cancer
J Dreo, S Lobentanzer, E Gaydukova, M Baric, AI Maarala, T Muranen, ...
Cancer Genomics, Multiomics and Computational Biology, 2024
12024
776P Multi-omics analysis of chemo-refractory high-grade serous carcinoma patients: Insights from the DECIDER study
D Afenteva, TA Muranen, A Rajavuori, S Jamalzadeh, K Zhang, V Ariotta, ...
Annals of Oncology 34, S525, 2023
12023
Development of a cloud-based machine learning system (CLOBNET) to predict platinum resistance in high-grade serous ovarian cancer.
VM Isoviita, L Salminen, J Azar, J Hynninen, R Lehtonen, P Roring, ...
CLINICAL CANCER RESEARCH 24 (15), 69-69, 2018
12018
Multi-Omics Analysis Reveals the Attenuation of the Interferon Pathway as a Driver of Chemo-Refractory Ovarian Cancer
D Afenteva, R Yu, A Rajavuori, M Salvadores, IM Launonen, K Lavikka, ...
bioRxiv, 2024.03. 28.587131, 2024
2024
# 240 Multi-omics characterization of chemo-refractory high-grade serous cancer
TA Muranen, D Afenteva, A Rajavuori, S Jamalzadeh, K Zhang, V Ariotta, ...
International Journal of Gynecologic Cancer 33 (Suppl 3), 2023
2023
Multi-omics characterization of chemo-refractory HGSC patients
TA Muranen, A Rajavuori, D Afenteva, K Huhtinen, VM Isoviita, ...
Cancer Research 83 (7_Supplement), 2135-2135, 2023
2023
Järjestystä munasarjasyövän genomiseen kaaokseen
A Lahtinen, K Lavikka, A Virtanen, Y Li, S Jamalzadeh, A Skorda, ...
Duodecim 139 (12), 1049, 2023
2023
Realized working hours and sleep among hospital physicians
K Karhula, T Hakola, VM Isoviita, S Puttonen, J Ervasti, T Oksanen, ...
Sleep Medicine 100, S88-S89, 2022
2022
582P Longitudinal, multi-sample characterization of HGSC from DECIDER: A Finnish observational study
J Oikkonen, A Virtanen, Y Li, VM Isoviita, K Zhang, S Jamalzadeh, ...
Annals of Oncology 33, S813, 2022
2022
Päivystävien sairaalalääkärien kokonaistyöaika kasvoi: Toteutuneet työajat 2014–2018
K Karhula, J Ervasti, T Hakola, VM Isoviita, I Kivimäki, M Kivimäki, ...
2022
Abstract A56: Development of a cloud-based machine learning system (CLOBNET) to predict platinum resistance in high-grade serous ovarian cancer
VM Isoviita, L Salminen, J Azar, J Hynninen, R Lehtonen, P Röring, ...
Clinical Cancer Research 24 (15_Supplement), A56-A56, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–20